Drug development

Address: 2F, No. 36, Lane 358
Juikuang Rd, Neihu
Taipei 114, Taiwan
公司名稱: 荷商台醫股份有限公司台灣分公司
Phone: +886-2-2627-2707
Fax: +886-2-2627-2708
Description:

Part of the AbGenomics Group, including AbGenomics International Inc., a clinical-stage biopharmaceutical company located in the San Francisco Bay Area.

Involved in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases, allergy, asthma, transplantation rejection, and cancer.

Lead candidate AbGn-168H (Neihulizumab) has demonstrated the proof of clinical efficacy in Phase II clinical trials for T-cell mediated diseases such as psoriasis and psoriatic arthritis.

地址: 台北市內湖區瑞光路358巷36號2F
Year Founded: 2000
Market: – na –
Address: 7F-1, No. 760, Sec. 4, Bade Rd, Songshan Dist, Taipei 105, Taiwan
公司名稱: 新源生物科技股份有限公司
Phone: +886-2-8787-1232
Fax: +886-2-8787-1239
Description:

Aims to discover, develop and bring to market novel small and large molecule drugs, with a focus on CNS and ophthalmology. Focus is on compound lead optimization to early clinical development.

Market: – na –
Address: 6F, No. 22, Sec. 2, Shengyi Rd, Zhubei City, Hsinchu County 30261, Taiwan
(Bldg D, 6F, Biotechnology Building, Hsinchu Biomedical Science Park)
公司名稱: 竟天生物科技股份有限公司
Phone: +886-3-658-1866
Fax: +886-3-658-1966
Description:

Creating new drug dosage forms using lipid-based microencapsulation for topical delivery and non-viral gene delivery systems.

地址: 30261新竹縣竹北市生醫路2段22號6F (新竹生物醫學園區生技大樓D棟6F)
Year Founded: 2008
Market: – na –
Address: 17F, No. 3, Park St, Nangang Dist, Taipei 115 , Taiwan
公司名稱: 圓祥生命科技股份有限公司
Phone: +886-2-2655-8010
Description:

Developing fully-human antibody-based biologics with novel mechanisms to fulfill unmet medical needs through proof-of-concept studies.

Has produced a portfolio of biologic leads with a primary clinical focus on cancer, autoimmune, and inflammatory diseases.

地址: 115台北市南港區園區街3號17F
Year Founded: 2013
Market: – na –
Address: Mackay Memorial Hospital Innovation & Incubation Center, No. 45, Minsheng Rd, Tamsui, New Taipei City 25160, Taiwan
公司名稱: 艾斯克立必恩股份有限公司
Phone: +886-2-2809-4661 ext. 3066
Description:

New drug development for cancer and eye diseases.

Market: – na –
Address: Rm. 536, Bldg. 52, 195, Sec. 4, Chunghsing Rd, Chutung, Hsinchu, 31040, Taiwan
公司名稱: 貝爾克斯生技股份有限公司
Phone: +886-3-591-0151 ext. 208
Fax: +886-3-591-0181
Description:

Developing botanically-derived new drugs to treat tumors and chronic liver diseases.

地址: 新竹縣竹東鎮中興路4段195號 (工研院育成中心52館536室)
Market: – na –
Address: 6F, No. 69, Xingai Rd, Neihu Dist, Taipei City 114, Taiwan
公司名稱: 保瑞藥業股份有限公司
Phone: +886-2-27901555
Fax: +886-2-27906595
Description:

Covers the entire pharmaceutical supply chain from research and development to sales and distribution. Provides outsourced R&D and manufacturing services for domestic and multinational pharmaceutical companies. PIC/S certified.

地址: 台北市內湖區行愛路69號6F
Market: – na –
Address: 8F, No. 1, Alley 30, Lane 358, Ruiguang Rd, Neihu Dist, Taipei 11492, Taiwan
公司名稱: 全福生物科技股份有限公司
Phone: +886-2-2659-8586
Fax: +886-2-2659-8779
Description:

Virtually operating company, focusing on developing new drugs in various areas including oncology and infectious disease. Focusing on translational medicine stage of drug development, team surveys many small molecules, peptides, biologics, and platform technologies at the lead optimization stage. Projects are brought into BRIM through co-development partnerships or in-licensing deals, and development of the projects is conducted at global CROs and CMOs that fit the needs of the project. Once clinical proof of concept (POC) is reached, the projects are partnered out for further clinical development.

地址: 11492台北市內湖區瑞光路358巷30弄1號8F
Year Founded: 2013
Market: – na –
Address: 3F, No. 65, Ln. 77, Xingai Rd, Neihu Dist, Taipei 114, Taiwan
公司名稱: 震泰生醫股份有限公司
Description:

Developer of immunotherapy for cancer treatment

Year Founded: 2016
Market: – na –
Address: No. 23, Hsiang Yang Rd., Taipei 10046, Taiwan
公司名稱: 中國化學製藥股份有限公司
Phone: +886-2-2312-4200
Fax: +886-2-2361-5143
Description:

Primarily generic pharmaceuticals. Strategy is to provide niche and high manufacturing complexity API and generic drugs, as well as 505(b)(2) class new drugs (new route of administration, new derivatives, new use, etc.).

Six manufacturing facilities in Taiwan.

Affiliates include:
Chunghwa Chemical Synthesis & Biotech Co., Ltd.: API manufacturer
Suzhou Chunghwa Chemical & Pharmaceutical Industrial Co., Ltd. (China)
Suzhou Chunghwa Yuming Pharmaceutical Co., Ltd. (China)
Chunghwa Yuming Healthcare Co., Ltd. (drug distribution)
Chunghwa Senior Care Co., Ltd. (seniors health care services)
Phermpep Co., Ltd. (peptide-based products for health)
Tai Rung Development Co., Ltd. (packaging products, ampoules, etc.)

地址: 台北市中正區襄陽路23號
Year Founded: 1952
Stock Ticker: 1701
Market: TaiEx